Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | ATM | Q13315 | 1/20 | 0.33 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.33 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.32 |
| ▸ | PDCD1 | Q15116 | 2/20 | 0.31 |
| ▸ | CD274 | Q9NZQ7 | 2/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.31 |
| ▸ | CA1 | P00915 | 1/20 | 0.30 |
| ▸ | CA2 | P00918 | 1/20 | 0.30 |
| ▸ | SSTR2 | P30874 | 1/20 | 0.30 |
| ▸ | PARP1 | P09874 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23476405 | 0.93 | MEN1 (0.36) | MEN1KMT2AATMDUSP3MAPK14 | |
| SCHEMBL19842419 | 0.89 | GRIN2B (0.32) | MEN1KMT2AATMPDCD1CD274 | |
| SCHEMBL24288920 | 0.88 | MEN1 (0.38) | MEN1KMT2AATMPDCD1CD274 | |
| SCHEMBL19842666 | 0.85 | SSTR2 (0.34) | MEN1KMT2AATMPDCD1CD274 | |
| SCHEMBL19842667 | 0.85 | SSTR2 (0.36) | MEN1KMT2AATMPDCD1CD274 | |
| SCHEMBL19850091 | 0.84 | MEN1 (0.40) | MEN1KMT2AATMDUSP3SMN1; SMN2 | |
| SCHEMBL24282762 | 0.83 | PDCD1 (0.33) | MEN1KMT2AATMPDCD1CD274 | |
| SCHEMBL19842389 | 0.82 | P2RX3 (0.37) | MEN1KMT2AATMSMN1; SMN2HIF1A | |
| SCHEMBL24282912 | 0.82 | PGR (0.32) | MEN1KMT2AATMMAPK14PDCD1 | |
| SCHEMBL23476503 | 0.82 | MEN1 (0.37) | MEN1KMT2AATMDUSP3MAPK14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210171501-A1 | ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | SAMSUNG DISPLAY CO., LTD. (KR) | 2021-06-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210171501-A1 | ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | L1CAM, OR10J3, AOX1 | MEN1 501/4885KMT2A 3763/4885ATM 4354/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.